LS_LBP_004

N/A

Report date: 2024/12/04 10:14:35

Base Information

Drug NameLS_LBP_004
Drug Alias NameLS_LBP_004LS-LBP-004LBP_004LBP-004
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionGastrointestinal microbiome modulatorsBacteria replacements
TargetsUpdating
Therapy Area/IndicationsAutism Spectrum Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Lishan Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Lishan Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAutism Spectrum Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A